The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 13, 2026 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma's promoter Aayush Agrawal (trustee of Aayush Agrawal Trust) reported simultaneous creation and release of pledge on 2,86,213 shares each (0.23% of total share capital) on May 12, 2026. The pledge was created in favour of Julius Baer Capital (India) Pvt Ltd for a new loan, and the same number of shares were released as the prior loan was repaid. Post-event, Aayush Agrawal Trust holds 1,41,12,924 shares (11.30%) with no net change in encumbered position. The combined promoter group holds approximately 75% of Ajanta Pharma.
The filing reflects a routine refinancing of promoter leverage — old loan repaid, new loan taken — with no net change in pledged holding. Neutral for shareholders as the promoter stake and encumbrance levels remain unchanged.